How Long Does ASCA Take for Medical Device Labs?

A regulatory timeline can be affected long before a test article enters the laboratory. For teams asking, how long does ASCA take, the useful answer is not a single number of days. FDA ASCA accreditation depends on the laboratory’s existing quality system, technical scope, assessment readiness, accreditation-body scheduling, and the completeness of the application package.

For a laboratory that already operates under ISO/IEC 17025 and has mature procedures for the relevant medical device standards, the process may be measured in months. A laboratory building a new scope, adding unfamiliar test methods, or resolving assessment findings should plan for a longer cycle. Device manufacturers should also separate the laboratory’s ASCA accreditation timeline from the turnaround time for their own testing program.

ASCA accreditation is generally not an immediate administrative approval. A practical planning range is often several months from readiness review through assessment, corrective-action closure, accreditation-body recommendation, and FDA action. Six months or more may be appropriate for a lab seeking a new or expanded scope, particularly when method validation, personnel competency evidence, equipment qualification, or assessment scheduling remains outstanding.

The timing can be shorter when the laboratory already holds applicable ISO/IEC 17025 accreditation, has performed the requested standards routinely, maintains complete technical records, and is prepared for an assessment against the ASCA program requirements. It can be longer where a laboratory needs to establish capability in a new discipline, such as electrical safety, ultrasound acoustic output, biocompatibility-related materials evaluation, or usability engineering.

No timeline should be treated as guaranteed. The accreditation body and FDA control key stages, while the laboratory controls readiness, response quality, and the ability to close findings with objective evidence.

What the ASCA Timeline Covers

The FDA Accreditation Scheme for Conformity Assessment, or ASCA, is intended to support medical device testing conducted to FDA-recognized consensus standards within an approved scope. It is not simply a laboratory marketing designation. The program relies on FDA-recognized accreditation bodies and laboratories that demonstrate conformance to applicable requirements.

A laboratory typically works through an FDA-recognized accreditation body for assessment and accreditation activities. The accreditation body evaluates the laboratory’s quality system and technical competence for the requested ASCA scope. Following the required review and recommendation process, FDA considers the laboratory’s ASCA accreditation.

That structure matters to manufacturers because an ASCA test report is only useful when the laboratory, test method, standard edition, and scope are aligned at the time the work is performed. A laboratory may be accredited to ISO/IEC 17025 generally while not yet holding ASCA accreditation for the exact standard or test discipline needed for a submission.

The Stages That Determine ASCA Timing

Readiness and scope definition

The first stage is often the most underestimated. The laboratory must define the standards and methods it intends to include, confirm that its requested scope is supported by its facilities and equipment, and identify any technical gaps. Broad requests can create unnecessary delays if the evidence is not equally mature across every requested method.

Readiness evidence commonly includes controlled procedures, calibration and maintenance records, method verification or validation data, uncertainty evaluations where applicable, personnel training and competency records, and records showing the laboratory can produce technically defensible reports. For medical device work, test setup controls, sample traceability, deviation handling, and report review are also central.

Application and assessment scheduling

Once documentation is ready, the laboratory submits its application through the appropriate accreditation process. Assessment dates depend on assessor availability, requested technical scope, the need for specialized expertise, and whether the evaluation can be completed remotely, on site, or through a combination of both.

Specialized medical device testing can require assessors with direct experience in the applicable standards. For example, evaluating competency for IEC 60601 electrical safety testing is materially different from assessing an acoustic output measurement program for diagnostic ultrasound. Scheduling the correct technical assessment resources may extend the calendar even when the laboratory is otherwise prepared.

Assessment findings and corrective actions

Most accreditation timelines are shaped by what happens after the assessment. Findings do not necessarily mean that accreditation is unlikely, but they require disciplined closure. The laboratory must identify the root cause, implement corrections, revise procedures or records where needed, and provide objective evidence that the issue has been resolved.

A minor documentation correction can close quickly. A finding involving method implementation, equipment performance, staff competency, or inadequate validation may require additional work and, in some cases, further review. Laboratories that submit concise, evidence-based corrective actions generally avoid the delays caused by repeated clarification requests.

Recommendation and FDA action

After the accreditation-body process is complete, the remaining program steps include recommendation and FDA consideration. This portion is not a testing turnaround commitment, and laboratories should avoid making commercial launch promises based on an assumed approval date.

For manufacturers, the operational question is straightforward: confirm the laboratory’s current ASCA status and applicable scope before authorizing testing intended to support an ASCA declaration. Do not assume that a pending application, a planned scope expansion, or prior work under another accreditation is interchangeable with active ASCA coverage.

Factors That Can Extend the Schedule

Several conditions consistently add time. A new laboratory quality system requires more evidence than an established ISO/IEC 17025 system. A newly introduced test method may need stronger demonstrations of repeatability, traceability, equipment suitability, and analyst competence. Changes to the requested scope during the process can also require reassessment or additional documentation.

The standard itself can affect planning. Some standards have multiple parts, collateral requirements, national deviations, or complex test configurations. A device platform with external power, patient connections, software-controlled modes, accessories, and multiple intended-use configurations can demand a more detailed test plan than a single-function bench instrument.

Capacity is another practical variable. Assessment calendars, laboratory workloads, availability of calibrated instruments, and access to representative test samples all affect progress. These issues are manageable, but they should be addressed in a project plan rather than discovered after a submission date has been committed.

ASCA Accreditation Time vs. Device Test Turnaround

Manufacturers often ask the question in a different sense: how long will ASCA-related testing take for a specific device? That is a separate estimate.

Once an appropriately accredited laboratory is selected, test timing depends on the applicable standard, device complexity, sample condition, documentation quality, test fixture needs, and any failures requiring engineering changes. A focused test program for a well-characterized device may progress efficiently. A full evaluation involving electrical safety, essential performance, ultrasound output, image quality, materials, or human factors can require coordinated work across multiple disciplines.

The shortest path is rarely the one with the fewest planned tests. It is the path that starts with a defined intended use, current device configuration, correct standard edition, complete risk documentation, and representative samples. Late design changes can invalidate portions of completed work or create the need for targeted retesting.

Questions to Resolve Before You Build a Submission Schedule

Regulatory and engineering teams should confirm whether the laboratory’s ASCA scope includes the exact standard and test activity required. They should also establish whether the current edition of the standard applies, what device configurations and accessories must be represented, and what evidence will be available before testing begins.

It is equally useful to ask how deviations, nonconformities, and retesting will be documented. A technically sound report should clearly identify the device tested, the methods used, applicable acceptance criteria, any departures from the plan, and the resulting data. These details affect not only the test schedule but also the review effort required to prepare a submission.

Plan ASCA Early, Not at the Report Stage

ASCA is most valuable when it is incorporated into verification planning before final design freeze. That gives the manufacturer time to select an appropriately accredited laboratory, align the test plan with the applicable scope, and resolve sample or documentation gaps before they become schedule-critical.

Sigma Scientific Services supports medical device manufacturers with standards-based testing performed within its applicable FDA ASCA and ISO/IEC 17025 accreditation scopes. For a realistic schedule, begin with the standard, device configuration, and evidence package – then confirm the laboratory scope before booking the work.